1. Statins, HIV, and CVD

2. Program Themes

3. Background

4. Causes of Increased CVD Risk in Persons Infected With HIV

5. Changes in Causes of Death for HIV-Diagnosed New Yorkers

6. Viral and ART Factors Ingredients in an "Atherogenic Soup"

7. 40-Year-Old Man Presents for HIV Care

8. Top Priority Initiate ART

9. Contemporary ART More Lipid Neutral

10. Case Study: 1 Year Later

11. Follow-Up Lipid Profile

12. Mean Changes in Blood Lipid Levels for 50 Seroconverters Initiating HAART

13. CVD Risk in Patients With HIV Infection

14. Assessment of CV Risk in the HIV-Infected Patient

15. How Is HIV Unique?

16. HIV-Specific Lipid Issues

17. Use of Statins With Protease Inhibitors

18. National Lipid Association Recommendations

19. Impact of Statins on Atherosclerosis in HIV

20. INTREPID

21. REPRIEVE Trial Design

22. Concluding Remarks

23. Abbreviations

24. Abbreviations (cont)